Moelis & vs Lazard Which Should You Buy?
Moelis & Company and Lazard Ltd. are two prominent investment banks that have gained significant recognition in the financial industry. Both firms offer a wide range of strategic advisory services, including mergers and acquisitions, restructurings, and capital raising. Moelis & Company has established a reputation for its client-focused approach and expertise in complex transactions, while Lazard is known for its global reach and long-standing relationships with corporations and governments. Investors interested in the financial sector may consider evaluating the stocks of these two companies for potential investment opportunities.
Moelis & or Lazard?
When comparing Moelis & and Lazard, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Moelis & and Lazard.
Dividend Investors:
Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company.
Moelis & has a dividend yield of 3.81%, while Lazard has a dividend yield of 4.13%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Moelis & reports a 5-year dividend growth of -5.88% year and a payout ratio of 135.39%. On the other hand, Lazard reports a 5-year dividend growth of 1.57% year and a payout ratio of 63.95%.
Value Investors:
Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Moelis & P/E ratio at 33.97 and Lazard's P/E ratio at 16.39. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Moelis & P/B ratio is 10.46 while Lazard's P/B ratio is 7.21.
Growth Investors:
Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Moelis & has seen a 5-year revenue growth of 0.12%, while Lazard's is 0.37%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Moelis &'s ROE at 35.53% and Lazard's ROE at 53.02%.
Retail Investors:
Retail investors often consider stock affordability and company familiarity. For example, day low prices are $63.70 for Moelis & and $46.17 for Lazard. Over the past year, Moelis &'s prices ranged from $46.24 to $82.89, with a yearly change of 79.26%. Lazard's prices fluctuated between $35.56 and $61.14, with a yearly change of 71.93%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.
